Table 1.
Demographic and clinical characteristics of patients according to lymphoma subtypes
| Tanı | Clinical status | N:276 (100%) |
|---|---|---|
| Hodgkin lymphoma (n = 45) | Female n (%) | 15 (33.3) |
| Median Age | 41.0(19.0–77.0) | |
| Presence of symptom B n (%) | 32 (71.1) | |
| Presence of bulky mass n (%) | 14 (31.1) | |
| Stage | 1 (2.2) | |
| I n (%) | ||
| II n (%) | 17 (37.8) | |
| III n (%) | 11 (24.4) | |
| IV n (%) | 16 (35.6) | |
| Follicular lymphoma (n = 46) | Female n (%) | 23 (50.0) |
| Median age | 60.0 (32.0–85.0) | |
| Presence of symptom B n (%) | 21(45.7) | |
| Presence of bulky mass n (%) | 16 (34.8) | |
| Stage | ||
| I n (%) | 3 (6.5) | |
| II n (%) | 5 (10.9) | |
| III n (%) | 15 (32.6) | |
| IV n (%) | 23 (50.0) | |
| Diffuse large B-cell lymphoma (n = 127) | Female n (%) | 57 (44.9) |
| Median age | 58.0 (18.0–86.0) | |
| Presence of symptom B n (%) | 77 (60.6) | |
| Presence of bulky mass n (%) | 59 (46.5) | |
| Stage | ||
| I n (%) | 5 (3.9) | |
| II n (%) | 42 (33.1) | |
| III n (%) | 51 (40.2) | |
| IV n (%) | 29 (22.8) | |
| Other non-Hodgkin lymphomas (n = 58) | Female n (%) | 13 (22.4) |
| Median age | 63.5 (20.0–85.0) | |
| Presence of symptom B n (%) | 26 (44.8) | |
| Presence of bulky mass n (%) | 13 (22.4) | |
| Stage | ||
| I n (%) | 2 (3.4) | |
| II n (%) | 4 (6.9) | |
| III n (%) | 10 (17.2) | |
| IV n (%) | 42 (72.4) |